Accredo
Privacy |  HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Nutropin AQ® (somatropin [rDNA origin]) - product information

Nutropin AQ® (somatropin [rDNA origin])

Overview | Product information | Accredo services | Contact team


Nutropin AQ is a liquid formulation that is administered with a syringe or in a cartridge formulation administered with its corresponding Nutropin AQ Pen® device.

Approved for the following diagnoses:

  • Growth hormone deficiency (GHD) in children and adults
  • Growth failure associated with chronic renal insufficiency (CRI) prior to kidney transplantation
  • Short stature associated with Turner syndrome
  • Idiopathic short stature

For more information on Nutropin AQ, please visit NutropinAQ.com or download the full prescribing information.


Nutropin AQ and Nutropin AQ Pen are registered trademarks of Genentech, Inc.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us